Sharma B

No ORCID on file · 7 papers in corpus · active 2004-2025

Study types

  • article 2

Condition tags

  • endometriosis 2
  • infertility 2
  • adenomyosis 1
2025
Journal of mid-life health ·doi:10.4103/jmh.jmh_71_25

Adenofibroma of the cervix is an extremely rare benign Mullerian mixed tumor, which contains both benign epithelial and mesenchymal tissue. The WHO 2020 classification of the female genital tract does not even include adenofibroma as a sepa…

2022
BMC medical genomics ·doi:10.1186/s12920-022-01320-x

BackgroundThe cause of infertility remains unclear in a significant proportion of reproductive-age couples who fail to conceive naturally. Chromosomal aberrations have been identified as one of the main genetic causes of male and female inf…

2021
·doi:10.21203/rs.3.rs-257989/v1

Abstract BackgroundDisruption in biological clock due to genetic variations is associated with increased occurrence of cancers such as breast, ovary, prostate, gastrointestinal and hematological malignancies. Circadian rhythm genes regulat…

article 2020
VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy ·doi:10.1016/j.vgie.2019.12.008

Endometriosis (EM) is the presence of endometrial tissue outside the uterine cavity.1Gustofson R.L. Kim N. Liu S. et al.Endometriosis and the appendix: a case series and comprehensive review of the literature.Fertil Steril. 2006; 86: 298-30…

2020
Scientific reports ·doi:10.1038/s41598-020-76491-7

Ovarian cancer (OC), a multifaceted and genetically heterogeneous malignancy is one of the most common cancers among women. The aim of the study is to unravel the genetic factors associated with OC and the extent of genetic heterogeneity in…

2005
Cancer imaging : the official publication of the International Cancer Imaging Society
article 2004
Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology ·doi:10.1080/01443610400019005

One hundred and twenty-three women underwent microwave endometrial ablation (MEA) for the treatment of dysfunctional uterine bleeding (DUB). The mean age at treatment was 40.2 years and the average treatment time was 2 minutes 50 seconds. A…